isoproterenol has been researched along with Cancer of Prostate in 8 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Androgen-independent prostate cancer cells DU-145 express a number of G protein-coupled receptors, including histamine H1 receptors." | 1.34 | Histamine augments beta2-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors. ( Arias-Montaño, JA; Camacho, J; López-Colombo, A; Ramos-Jiménez, J; Reyes-Esparza, JA; Soria-Jasso, LE, 2007) |
| "A human prostate cancer cell line (PC3) with abundant neurotensin (NT) receptors was used to demonstrate that NT potentiated 3',5'-cyclic adenosine monophate (cAMP) accumulation in response to a variety of stimuli, including both direct forskolin (F) and indirect (prostaglandin, (PGE2), isoproterenol (ISO) and cholera toxin (CTx)) activators of adenylyl cyclase." | 1.30 | Neurotensin enhances agonist-induced cAMP accumulation in PC3 cells via Ca2+ -dependent adenylyl cyclase(s). ( Carraway, RE; Mitra, SP, 1998) |
| "In this study, we used prostate cancer PC3 cells, which express neurotensin receptors and 12-adrenergic receptors, to demonstrate that neurotensin can potentiate the effects of isoproterenol on 3',5'-cyclic adenosine monophosphate (cAMP) formation and on inhibition of DNA synthesis." | 1.30 | Synergistic effects of neurotensin and beta-adrenergic agonist on 3,5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells. ( Carraway, RE; Mitra, SP, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Z | 1 |
| Li, G | 1 |
| Zhang, Z | 1 |
| Gu, R | 1 |
| Wang, W | 1 |
| Lai, X | 1 |
| Cui, ZK | 1 |
| Zeng, F | 1 |
| Xu, S | 1 |
| Deng, F | 1 |
| Zhang, M | 1 |
| Wang, Q | 1 |
| Sun, X | 1 |
| Yin, Q | 1 |
| Chen, J | 1 |
| Xu, L | 1 |
| Xu, C | 1 |
| Zhang, P | 1 |
| He, X | 1 |
| Tan, J | 1 |
| Zhou, X | 1 |
| Zou, L | 1 |
| Kasbohm, EA | 1 |
| Guo, R | 1 |
| Yowell, CW | 1 |
| Bagchi, G | 1 |
| Kelly, P | 1 |
| Arora, P | 1 |
| Casey, PJ | 1 |
| Daaka, Y | 1 |
| Ramos-Jiménez, J | 1 |
| Soria-Jasso, LE | 1 |
| López-Colombo, A | 1 |
| Reyes-Esparza, JA | 1 |
| Camacho, J | 1 |
| Arias-Montaño, JA | 1 |
| Carraway, RE | 2 |
| Mitra, SP | 2 |
| Cox, ME | 1 |
| Deeble, PD | 1 |
| Lakhani, S | 1 |
| Parsons, SJ | 1 |
8 other studies available for isoproterenol and Cancer of Prostate
| Article | Year |
|---|---|
β2AR-HIF-1α-CXCL12 signaling of osteoblasts activated by isoproterenol promotes migration and invasion of prostate cancer cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Chemokine CXCL12; Culture Media, Conditioned; Epithelial-M | 2019 |
β
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Disease Progress | 2020 |
β-arrestin2 mediates β-2 adrenergic receptor signaling inducing prostate cancer cell progression.
Topics: Adrenergic beta-2 Receptor Agonists; Arrestins; beta-Arrestins; Cell Line, Tumor; Cell Movement; Cel | 2011 |
Androgen receptor activation by G(s) signaling in prostate cancer cells.
Topics: Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dihydrotestosterone; GTP-Binding Protein alpha Sub | 2005 |
Histamine augments beta2-adrenoceptor-induced cyclic AMP accumulation in human prostate cancer cells DU-145 independently of known histamine receptors.
Topics: Cell Line, Tumor; Cyclic AMP; Dihydroalprenolol; Histamine; Humans; Isoproterenol; Male; Prostatic N | 2007 |
Neurotensin enhances agonist-induced cAMP accumulation in PC3 cells via Ca2+ -dependent adenylyl cyclase(s).
Topics: Adenylyl Cyclases; Calcium; Cholera Toxin; Colforsin; Cyclic AMP; Dinoprostone; Drug Synergism; Egta | 1998 |
Synergistic effects of neurotensin and beta-adrenergic agonist on 3,5-cyclic adenosine monophosphate accumulation and DNA synthesis in prostate cancer PC3 cells.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Bucladesine; Cell Division; Cyclic AMP; DNA; | 1999 |
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible: implications for prostate cancer progression.
Topics: 1-Methyl-3-isobutylxanthine; Adenocarcinoma; Androgens; Biomarkers; Bombesin; Bucladesine; Calcium-C | 1999 |